Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EscharEx in Debridement of Venous Leg Ulcers (VALUE)
NCT06568627Phase 3Recruiting
- Sponsor
- MediWound
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of EscharEx in venous leg ulcer (VLU), sponsored by MediWound. Started Jun 2025; status: recruiting.
02
Drugs
EscharEx
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT06568627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06568627.